Singapore scientists have developed a universal drug against cancer. ETC-159 – the first anticancer agent, established in the country and passed all required tests. Now comes the phase of clinical trials. If successful, the world will have a new effective drug for the treatment of cancer, reports Xinhua.
Cancer is one of the leading causes of death in Singapore. It accounts for every third fatal case in the country. Every year from cancer worldwide are killed 8.2 million people. ETC-159 works against colon cancer, ovarian cancer, pancreatic cancer. All of these types of cancer combined in one mechanism – cellular Wnt signalling pathways.
By increasing the activity of these pathways and increases the ability of cancer cells to grow and spread. Now undergoing the first phase of clinical trials to evaluate the safety and tolerability of the drug. In the test group consisted of 58 patients with cancer.